X-38033933-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_138780.3(SYTL5):āc.44A>Gā(p.Asp15Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000801 in 1,198,845 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 23 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000089 ( 0 hom., 5 hem., cov: 24)
Exomes š: 0.000079 ( 0 hom. 18 hem. )
Consequence
SYTL5
NM_138780.3 missense
NM_138780.3 missense
Scores
1
11
5
Clinical Significance
Conservation
PhyloP100: 6.72
Genes affected
SYTL5 (HGNC:15589): (synaptotagmin like 5) The protein encoded by this gene belongs to the synaptotagmin-like (Slp) protein family, which contains a unique homology domain at the N-terminus, referred to as the Slp homology domain (SHD). The SHD functions as a binding site for Rab27A, which plays a role in protein transport. Expression of this gene is restricted to placenta and liver, suggesting that it might be involved in Rab27A-dependent membrane trafficking in specific tissues. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAd4 at 5 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SYTL5 | NM_138780.3 | c.44A>G | p.Asp15Gly | missense_variant | 2/17 | ENST00000297875.7 | NP_620135.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SYTL5 | ENST00000297875.7 | c.44A>G | p.Asp15Gly | missense_variant | 2/17 | 5 | NM_138780.3 | ENSP00000297875 | P4 | |
SYTL5 | ENST00000456733.2 | c.44A>G | p.Asp15Gly | missense_variant | 1/17 | 1 | ENSP00000395220 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000888 AC: 10AN: 112672Hom.: 0 Cov.: 24 AF XY: 0.000144 AC XY: 5AN XY: 34840
GnomAD3 genomes
AF:
AC:
10
AN:
112672
Hom.:
Cov.:
24
AF XY:
AC XY:
5
AN XY:
34840
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000621 AC: 11AN: 177026Hom.: 0 AF XY: 0.0000162 AC XY: 1AN XY: 61830
GnomAD3 exomes
AF:
AC:
11
AN:
177026
Hom.:
AF XY:
AC XY:
1
AN XY:
61830
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000792 AC: 86AN: 1086119Hom.: 0 Cov.: 25 AF XY: 0.0000510 AC XY: 18AN XY: 352615
GnomAD4 exome
AF:
AC:
86
AN:
1086119
Hom.:
Cov.:
25
AF XY:
AC XY:
18
AN XY:
352615
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000887 AC: 10AN: 112726Hom.: 0 Cov.: 24 AF XY: 0.000143 AC XY: 5AN XY: 34904
GnomAD4 genome
AF:
AC:
10
AN:
112726
Hom.:
Cov.:
24
AF XY:
AC XY:
5
AN XY:
34904
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ExAC
AF:
AC:
7
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2024 | The c.44A>G (p.D15G) alteration is located in exon 2 (coding exon 1) of the SYTL5 gene. This alteration results from a A to G substitution at nucleotide position 44, causing the aspartic acid (D) at amino acid position 15 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M;M
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
P;.
Vest4
MVP
MPC
0.13
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: 0
Find out detailed SpliceAI scores and Pangolin per-transcript scores at